ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Tissue Diagnostics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-30J982
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Tissue Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cancer Tissue Diagnostics Market Research Report 2025

Code: QYRE-Auto-30J982
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
F Hoffmann La Roche Ltd
Danaher Corporation
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc
Abbott
Enzo Life sciences Inc
Agilent Technologies Inc
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam

Cancer Tissue Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cancer Tissue Diagnostics Market

Cancer Tissue Diagnostics Market

The global market for Cancer Tissue Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancer Tissue Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tissue Diagnostics.
The Cancer Tissue Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Tissue Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Tissue Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Tissue Diagnostics Market Report

Report Metric Details
Report Name Cancer Tissue Diagnostics Market
CAGR 5%
Segment by Type
  • Immunohistochemistry (IHC) Test
  • In Situ Hybridisation Test
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Agilent Technologies, Inc., Cancer Genetics Inc., Merck KGaA (Sigma-Aldrich Co. LLC), Abcam plc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Tissue Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Tissue Diagnostics Market report?

Ans: The main players in the Cancer Tissue Diagnostics Market are F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Agilent Technologies, Inc., Cancer Genetics Inc., Merck KGaA (Sigma-Aldrich Co. LLC), Abcam plc.

What are the Application segmentation covered in the Cancer Tissue Diagnostics Market report?

Ans: The Applications covered in the Cancer Tissue Diagnostics Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Cancer Tissue Diagnostics Market report?

Ans: The Types covered in the Cancer Tissue Diagnostics Market report are Immunohistochemistry (IHC) Test, In Situ Hybridisation Test

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunohistochemistry (IHC) Test
1.2.3 In Situ Hybridisation Test
1.3 Market by Application
1.3.1 Global Cancer Tissue Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tissue Diagnostics Market Perspective (2020-2031)
2.2 Global Cancer Tissue Diagnostics Growth Trends by Region
2.2.1 Global Cancer Tissue Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Tissue Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Cancer Tissue Diagnostics Market Dynamics
2.3.1 Cancer Tissue Diagnostics Industry Trends
2.3.2 Cancer Tissue Diagnostics Market Drivers
2.3.3 Cancer Tissue Diagnostics Market Challenges
2.3.4 Cancer Tissue Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Revenue
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Tissue Diagnostics Revenue
3.4 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2024
3.5 Global Key Players of Cancer Tissue Diagnostics Head office and Area Served
3.6 Global Key Players of Cancer Tissue Diagnostics, Product and Application
3.7 Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tissue Diagnostics Breakdown Data by Type
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031)
5 Cancer Tissue Diagnostics Breakdown Data by Application
5.1 Global Cancer Tissue Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2020-2031)
6.2 North America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
6.4 North America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2020-2031)
7.2 Europe Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025)
7.4 Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tissue Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Cancer Tissue Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Tissue Diagnostics Market Size (2020-2031)
9.2 Latin America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tissue Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
11.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Details
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Bio Rad Laboratories Inc.
11.4.1 Bio Rad Laboratories Inc. Company Details
11.4.2 Bio Rad Laboratories Inc. Business Overview
11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
11.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.4.5 Bio Rad Laboratories Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Cancer Tissue Diagnostics Introduction
11.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Details
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 Agilent Technologies, Inc.
11.7.1 Agilent Technologies, Inc. Company Details
11.7.2 Agilent Technologies, Inc. Business Overview
11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
11.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.7.5 Agilent Technologies, Inc. Recent Development
11.8 Cancer Genetics Inc.
11.8.1 Cancer Genetics Inc. Company Details
11.8.2 Cancer Genetics Inc. Business Overview
11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
11.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.8.5 Cancer Genetics Inc. Recent Development
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
11.10 Abcam plc.
11.10.1 Abcam plc. Company Details
11.10.2 Abcam plc. Business Overview
11.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
11.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.10.5 Abcam plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
F Hoffmann La Roche Ltd
Danaher Corporation
Thermo Fisher Scientific Inc
Bio-Rad Laboratories Inc
Abbott
Enzo Life sciences Inc
Agilent Technologies Inc
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam
List of Tables
 Table 1. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunohistochemistry (IHC) Test
 Table 3. Key Players of In Situ Hybridisation Test
 Table 4. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cancer Tissue Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cancer Tissue Diagnostics Market Share by Region (2020-2025)
 Table 8. Global Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cancer Tissue Diagnostics Market Share by Region (2026-2031)
 Table 10. Cancer Tissue Diagnostics Market Trends
 Table 11. Cancer Tissue Diagnostics Market Drivers
 Table 12. Cancer Tissue Diagnostics Market Challenges
 Table 13. Cancer Tissue Diagnostics Market Restraints
 Table 14. Global Cancer Tissue Diagnostics Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cancer Tissue Diagnostics Market Share by Players (2020-2025)
 Table 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
 Table 17. Ranking of Global Top Cancer Tissue Diagnostics Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cancer Tissue Diagnostics Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cancer Tissue Diagnostics, Headquarters and Area Served
 Table 20. Global Key Players of Cancer Tissue Diagnostics, Product and Application
 Table 21. Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cancer Tissue Diagnostics Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2020-2025)
 Table 25. Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2026-2031)
 Table 27. Global Cancer Tissue Diagnostics Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2020-2025)
 Table 29. Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2026-2031)
 Table 31. North America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cancer Tissue Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. F. Hoffmann-La Roche Ltd. Company Details
 Table 47. F. Hoffmann-La Roche Ltd. Business Overview
 Table 48. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product
 Table 49. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 50. F. Hoffmann-La Roche Ltd. Recent Development
 Table 51. Danaher Corporation Company Details
 Table 52. Danaher Corporation Business Overview
 Table 53. Danaher Corporation Cancer Tissue Diagnostics Product
 Table 54. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 55. Danaher Corporation Recent Development
 Table 56. Thermo Fisher Scientific Inc. Company Details
 Table 57. Thermo Fisher Scientific Inc. Business Overview
 Table 58. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product
 Table 59. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 60. Thermo Fisher Scientific Inc. Recent Development
 Table 61. Bio Rad Laboratories Inc. Company Details
 Table 62. Bio Rad Laboratories Inc. Business Overview
 Table 63. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product
 Table 64. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 65. Bio Rad Laboratories Inc. Recent Development
 Table 66. Abbott Company Details
 Table 67. Abbott Business Overview
 Table 68. Abbott Cancer Tissue Diagnostics Product
 Table 69. Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 70. Abbott Recent Development
 Table 71. Enzo Life Sciences, Inc. Company Details
 Table 72. Enzo Life Sciences, Inc. Business Overview
 Table 73. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product
 Table 74. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 75. Enzo Life Sciences, Inc. Recent Development
 Table 76. Agilent Technologies, Inc. Company Details
 Table 77. Agilent Technologies, Inc. Business Overview
 Table 78. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product
 Table 79. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 80. Agilent Technologies, Inc. Recent Development
 Table 81. Cancer Genetics Inc. Company Details
 Table 82. Cancer Genetics Inc. Business Overview
 Table 83. Cancer Genetics Inc. Cancer Tissue Diagnostics Product
 Table 84. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 85. Cancer Genetics Inc. Recent Development
 Table 86. Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
 Table 87. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
 Table 88. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product
 Table 89. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 90. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
 Table 91. Abcam plc. Company Details
 Table 92. Abcam plc. Business Overview
 Table 93. Abcam plc. Cancer Tissue Diagnostics Product
 Table 94. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
 Table 95. Abcam plc. Recent Development
 Table 96. Research Programs/Design for This Report
 Table 97. Key Data Information from Secondary Sources
 Table 98. Key Data Information from Primary Sources
 Table 99. Authors List of This Report


List of Figures
 Figure 1. Cancer Tissue Diagnostics Picture
 Figure 2. Global Cancer Tissue Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Tissue Diagnostics Market Share by Type: 2024 VS 2031
 Figure 4. Immunohistochemistry (IHC) Test Features
 Figure 5. In Situ Hybridisation Test Features
 Figure 6. Global Cancer Tissue Diagnostics Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cancer Tissue Diagnostics Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Others Case Studies
 Figure 11. Cancer Tissue Diagnostics Report Years Considered
 Figure 12. Global Cancer Tissue Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cancer Tissue Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cancer Tissue Diagnostics Market Share by Region: 2024 VS 2031
 Figure 15. Global Cancer Tissue Diagnostics Market Share by Players in 2024
 Figure 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2024
 Figure 18. North America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
 Figure 20. United States Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cancer Tissue Diagnostics Market Share by Country (2020-2031)
 Figure 24. Germany Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cancer Tissue Diagnostics Market Share by Region (2020-2031)
 Figure 32. China Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
 Figure 40. Mexico Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cancer Tissue Diagnostics Market Share by Country (2020-2031)
 Figure 44. Turkey Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 48. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 49. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 50. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 51. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 52. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 54. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 55. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 56. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Diagnostics Service Market Research Report 2025
Global Gynecological Cancer Diagnostics Market Research Report 2025
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Global Kidney Cancer Diagnosis Market Research Report 2025
Global Lung Cancer Diagnostic Tests Market Research Report 2024
Brain Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non invasive Cancer Diagnosis Market Research Report 2024
Global Cancer Diagnostic Kit Market Research Report 2024
Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Precision Diagnostic Market Research Report 2024
Next Generation Breast Cancer Diagnostic and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Personalized Medicine for Cancer Market Research Report 2025
Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2024
AI for Cancer Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Next Generation Gynecological Cancer Diagnostics Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions